M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Total Receivables Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Total Receivables
€5m
CAGR 3-Years
37%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Receivables
€30.5m
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
23%
G
Genfit SA
PAR:GNFT
Total Receivables
€71m
CAGR 3-Years
72%
CAGR 5-Years
30%
CAGR 10-Years
44%
Inventiva SA
PAR:IVA
Total Receivables
€16.2m
CAGR 3-Years
42%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Total Receivables
€31.6m
CAGR 3-Years
-17%
CAGR 5-Years
12%
CAGR 10-Years
14%
OSE Immunotherapeutics SA
PAR:OSE
Total Receivables
€7.6m
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Total Receivables?
Total Receivables
5m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Total Receivables amounts to 5m EUR.

What is Maat Pharma SA's Total Receivables growth rate?
Total Receivables CAGR 5Y
37%

Over the last year, the Total Receivables growth was 8%. The average annual Total Receivables growth rates for Maat Pharma SA have been 37% over the past three years , 37% over the past five years .

Back to Top